Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-29 Payton Lori Chief Development Officer Grant or award · Stock Option (Right to Buy) +99,827 99,827
2026-10-29 Alford Rachael Chief Operating Officer Grant or award · Stock Option (Right to Buy) +89,844 89,844
2026-10-29 Frey Rebecca Chief Executive Officer Grant or award · Stock Option (Right to Buy) +465,857 465,857
2026-10-29 Ryder Steven Chief Medical Officer Grant or award · Stock Option (Right to Buy) +113,137 113,137
2026-10-29 Zeronda Tyler Chief Financial Officer Grant or award · Stock Option (Right to Buy) +156,115 156,115
2026-07-29 RTW Fund Group GP, LLC 10% owner Other disposition −133,290 266,307
2026-07-29 RTW Fund Group GP, LLC 10% owner Other acquisition · Pre-Funded Warrants (Right to Buy) +133,290 8,949,719
2026-07-27 Ashiya Mona Director Grant or award · Stock Option (Right to Buy) +15,435 15,435
2026-07-27 Zeronda Tyler Director Grant or award · Stock Option (Right to Buy) +185,798 185,798
2026-07-23 Zeronda Tyler CHIEF FINANCIAL OFFICER Shares withheld for taxes −22,516 $0.90 $20K 74,918
2026-07-23 Harsch Mutya CHIEF LEGAL OFFICER AND GC Shares withheld for taxes −22,516 $0.90 $20K 95,918
2026-07-23 Domzalski David PRESIDENT AND CEO Shares withheld for taxes −79,391 $0.90 $71K 347,174
2026-07-23 Stuart Iain CHIEF SCIENTIFIC OFFICER Shares withheld for taxes −15,405 $0.90 $14K 95,944
2026-06-30 Zeronda Tyler CHIEF FINANCIAL OFFICER Shares withheld for taxes −3,464 $0.65 $2K 97,434
2026-06-30 Harsch Mutya CHIEF LEGAL OFFICER AND GC Shares withheld for taxes −3,464 $0.65 $2K 118,434
2026-06-30 Domzalski David PRESIDENT AND CEO Shares withheld for taxes −12,214 $0.65 $8K 426,565
2026-06-30 Stuart Iain CHIEF SCIENTIFIC OFFICER Shares withheld for taxes −2,370 $0.65 $2K 111,349
2026-05-29 Domzalski David PRESIDENT AND CEO Grant or award +30,791 $0.31 $10K 438,779
2026-03-31 Zeronda Tyler CHIEF FINANCIAL OFFICER Shares withheld for taxes −4,007 $0.60 $2K 99,788
2026-03-31 Harsch Mutya CHIEF LEGAL OFFICER AND GC Shares withheld for taxes −4,007 $0.60 $2K 121,898

Page 1 of 22 · 425 trades